Even after the pause was lifted, confidence in the shot was low and demand faded. Then regulators limited use of the vaccine., it was praised: Two rivals were joining forces to produce the single-dose shot in a time of crisis. Johnson & Johnson was to utilize two of Merck’s manufacturing plants for production, and Merck said in a statement at the time that it looked forward to “combining our expertise with Johnson & Johnson to help increase supply and expand access...
But issues arose, according to The Wall Street Journal. There were technical glitches and delays getting ingredients at a plant, among other problems. In October 2022, Johnson & Johnson filed an arbitration demand against Merck over the partnership, the report said, with Merck filing a counterclaim.Our journalism needs your support. Please
I guess people are finally waking up and realizing that the vaccine is a bioweapon meant to depopulate the planet. So glad I didn't fall for this nonsense.
People no longer believe in the vaccine ? Hmmmm